Here’s everything you need to know about Friday’s big jobs report
A gradual slowdown in the economy and Hurricane Beryl are expected to have taken some of the steam out of hiring in July.
Elon Musk sued by ex-CNN anchor Don Lemon over canceled X deal
The deal to host “The Don Lemon Show” on X was scrapped after the taping of its premiere episode, a one-on-one interview with Elon Musk.
Kamala Harris has a murky antitrust record. Wall Street sees an opportunity
Kamala Harris served as California’s attorney general and a senator before becoming the vice president.
Putin’s Trader: How Russian hackers stole millions from U.S. investors
This CNBC documentary is about the rise and fall of Vladislav Klyushin and his business empire. Klyushin was just released from a U.S. prison in a prisoner swap.
Amazon shares slide on revenue miss, disappointing guidance for third quarter
Amazon missed on revenue for the second quarter and gave a forecast for the current quarter that fell short of Wall Street’s expectations.
Apple sales rise 5%, topping estimates as iPad and Services revenues jump
Apple reported earnings after the bell on Thursday.
Your health records are coming to new apps. Here’s why
It’s about to get a lot easier for patients in the U.S. to access their own medical records.
Markets are clamoring for the Fed to start cutting soon: ‘What is it they’re looking for?’
Markets are pricing in an aggressive path for interest rate cuts starting in September.
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.
